Financhill
Sell
17

HCTI Quote, Financials, Valuation and Earnings

Last price:
$1.34
Seasonality move :
-13.67%
Day range:
$1.85 - $1.97
52-week range:
$1.37 - $435.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.26x
P/B ratio:
8.60x
Volume:
196.9K
Avg. volume:
308.5K
1-year change:
-99.06%
Market cap:
$11.3M
Revenue:
$11.7M
EPS (TTM):
-$103.25

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
HCTI
Healthcare Triangle, Inc.
$5M -$0.22 178.81% -99.66% $6.00
CERT
Certara, Inc.
$104.6M $0.11 3.04% 150.07% $12.54
DRIO
DarioHealth Corp.
$5.7M -$2.42 -32.08% -68.96% $18.25
GDRX
GoodRx Holdings, Inc.
$194.5M $0.09 -2.9% 420.34% $4.88
NRC
National Research Corp.
-- -- -- -- --
SPOK
Spok Holdings, Inc.
$35.9M $0.24 2.09% 18.18% $20.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
HCTI
Healthcare Triangle, Inc.
$1.93 $6.00 $11.3M -- $0.00 0% 0.26x
CERT
Certara, Inc.
$9.07 $12.54 $1.4B 134.37x $0.00 0% 3.51x
DRIO
DarioHealth Corp.
$11.54 $18.25 $27.7M -- $0.00 0% 6.41x
GDRX
GoodRx Holdings, Inc.
$2.77 $4.88 $940.2M 32.25x $0.00 0% 1.27x
NRC
National Research Corp.
$18.70 -- $423.7M 26.53x $0.12 2.57% 3.06x
SPOK
Spok Holdings, Inc.
$12.93 $20.00 $266.3M 16.16x $0.31 9.67% 1.92x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
HCTI
Healthcare Triangle, Inc.
14.89% 5.607 6.72% 1.08x
CERT
Certara, Inc.
22.36% 0.910 15.74% 1.94x
DRIO
DarioHealth Corp.
29.69% 1.040 75.99% 3.72x
GDRX
GoodRx Holdings, Inc.
47.58% 0.637 37.77% 2.62x
NRC
National Research Corp.
84.83% 2.343 28.57% 0.39x
SPOK
Spok Holdings, Inc.
4.71% 0.927 2.07% 0.97x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
HCTI
Healthcare Triangle, Inc.
$555K -$2.6M -116.94% -153.6% -74.26% -$2.7M
CERT
Certara, Inc.
$50.9M $6.8M 0.79% 1.02% 6.53% $25.5M
DRIO
DarioHealth Corp.
$3M -$9.5M -28.66% -41.55% -189.42% -$7.4M
GDRX
GoodRx Holdings, Inc.
$161.2M $26.4M 2.63% 4.78% 13.48% $58M
NRC
National Research Corp.
$20M $7.7M 17.01% 61.55% 22.36% $10.2M
SPOK
Spok Holdings, Inc.
$20M $4.5M 10.33% 10.88% 13.38% $7.6M

Healthcare Triangle, Inc. vs. Competitors

  • Which has Higher Returns HCTI or CERT?

    Certara, Inc. has a net margin of -54.63% compared to Healthcare Triangle, Inc.'s net margin of 1.46%. Healthcare Triangle, Inc.'s return on equity of -153.6% beat Certara, Inc.'s return on equity of 1.02%.

    Company Gross Margin Earnings Per Share Invested Capital
    HCTI
    Healthcare Triangle, Inc.
    15.91% -$0.43 $10.3M
    CERT
    Certara, Inc.
    48.67% $0.01 $1.4B
  • What do Analysts Say About HCTI or CERT?

    Healthcare Triangle, Inc. has a consensus price target of $6.00, signalling upside risk potential of 159.07%. On the other hand Certara, Inc. has an analysts' consensus of $12.54 which suggests that it could grow by 38.28%. Given that Healthcare Triangle, Inc. has higher upside potential than Certara, Inc., analysts believe Healthcare Triangle, Inc. is more attractive than Certara, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    HCTI
    Healthcare Triangle, Inc.
    0 0 0
    CERT
    Certara, Inc.
    6 7 0
  • Is HCTI or CERT More Risky?

    Healthcare Triangle, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Certara, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HCTI or CERT?

    Healthcare Triangle, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Certara, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Healthcare Triangle, Inc. pays -- of its earnings as a dividend. Certara, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HCTI or CERT?

    Healthcare Triangle, Inc. quarterly revenues are $3.5M, which are smaller than Certara, Inc. quarterly revenues of $104.6M. Healthcare Triangle, Inc.'s net income of -$1.9M is lower than Certara, Inc.'s net income of $1.5M. Notably, Healthcare Triangle, Inc.'s price-to-earnings ratio is -- while Certara, Inc.'s PE ratio is 134.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Triangle, Inc. is 0.26x versus 3.51x for Certara, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HCTI
    Healthcare Triangle, Inc.
    0.26x -- $3.5M -$1.9M
    CERT
    Certara, Inc.
    3.51x 134.37x $104.6M $1.5M
  • Which has Higher Returns HCTI or DRIO?

    DarioHealth Corp. has a net margin of -54.63% compared to Healthcare Triangle, Inc.'s net margin of -41.48%. Healthcare Triangle, Inc.'s return on equity of -153.6% beat DarioHealth Corp.'s return on equity of -41.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    HCTI
    Healthcare Triangle, Inc.
    15.91% -$0.43 $10.3M
    DRIO
    DarioHealth Corp.
    60.22% -$3.05 $106.6M
  • What do Analysts Say About HCTI or DRIO?

    Healthcare Triangle, Inc. has a consensus price target of $6.00, signalling upside risk potential of 159.07%. On the other hand DarioHealth Corp. has an analysts' consensus of $18.25 which suggests that it could grow by 58.15%. Given that Healthcare Triangle, Inc. has higher upside potential than DarioHealth Corp., analysts believe Healthcare Triangle, Inc. is more attractive than DarioHealth Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    HCTI
    Healthcare Triangle, Inc.
    0 0 0
    DRIO
    DarioHealth Corp.
    3 1 0
  • Is HCTI or DRIO More Risky?

    Healthcare Triangle, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.077, suggesting its more volatile than the S&P 500 by 7.716%.

  • Which is a Better Dividend Stock HCTI or DRIO?

    Healthcare Triangle, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Healthcare Triangle, Inc. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HCTI or DRIO?

    Healthcare Triangle, Inc. quarterly revenues are $3.5M, which are smaller than DarioHealth Corp. quarterly revenues of $5M. Healthcare Triangle, Inc.'s net income of -$1.9M is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, Healthcare Triangle, Inc.'s price-to-earnings ratio is -- while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Triangle, Inc. is 0.26x versus 6.41x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HCTI
    Healthcare Triangle, Inc.
    0.26x -- $3.5M -$1.9M
    DRIO
    DarioHealth Corp.
    6.41x -- $5M -$2.1M
  • Which has Higher Returns HCTI or GDRX?

    GoodRx Holdings, Inc. has a net margin of -54.63% compared to Healthcare Triangle, Inc.'s net margin of 0.57%. Healthcare Triangle, Inc.'s return on equity of -153.6% beat GoodRx Holdings, Inc.'s return on equity of 4.78%.

    Company Gross Margin Earnings Per Share Invested Capital
    HCTI
    Healthcare Triangle, Inc.
    15.91% -$0.43 $10.3M
    GDRX
    GoodRx Holdings, Inc.
    82.22% $0.00 $1.1B
  • What do Analysts Say About HCTI or GDRX?

    Healthcare Triangle, Inc. has a consensus price target of $6.00, signalling upside risk potential of 159.07%. On the other hand GoodRx Holdings, Inc. has an analysts' consensus of $4.88 which suggests that it could grow by 76.29%. Given that Healthcare Triangle, Inc. has higher upside potential than GoodRx Holdings, Inc., analysts believe Healthcare Triangle, Inc. is more attractive than GoodRx Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    HCTI
    Healthcare Triangle, Inc.
    0 0 0
    GDRX
    GoodRx Holdings, Inc.
    6 5 0
  • Is HCTI or GDRX More Risky?

    Healthcare Triangle, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GoodRx Holdings, Inc. has a beta of 1.470, suggesting its more volatile than the S&P 500 by 47.004%.

  • Which is a Better Dividend Stock HCTI or GDRX?

    Healthcare Triangle, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GoodRx Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Healthcare Triangle, Inc. pays -- of its earnings as a dividend. GoodRx Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HCTI or GDRX?

    Healthcare Triangle, Inc. quarterly revenues are $3.5M, which are smaller than GoodRx Holdings, Inc. quarterly revenues of $196M. Healthcare Triangle, Inc.'s net income of -$1.9M is lower than GoodRx Holdings, Inc.'s net income of $1.1M. Notably, Healthcare Triangle, Inc.'s price-to-earnings ratio is -- while GoodRx Holdings, Inc.'s PE ratio is 32.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Triangle, Inc. is 0.26x versus 1.27x for GoodRx Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HCTI
    Healthcare Triangle, Inc.
    0.26x -- $3.5M -$1.9M
    GDRX
    GoodRx Holdings, Inc.
    1.27x 32.25x $196M $1.1M
  • Which has Higher Returns HCTI or NRC?

    National Research Corp. has a net margin of -54.63% compared to Healthcare Triangle, Inc.'s net margin of 11.54%. Healthcare Triangle, Inc.'s return on equity of -153.6% beat National Research Corp.'s return on equity of 61.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    HCTI
    Healthcare Triangle, Inc.
    15.91% -$0.43 $10.3M
    NRC
    National Research Corp.
    57.82% $0.18 $94.4M
  • What do Analysts Say About HCTI or NRC?

    Healthcare Triangle, Inc. has a consensus price target of $6.00, signalling upside risk potential of 159.07%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Healthcare Triangle, Inc. has higher upside potential than National Research Corp., analysts believe Healthcare Triangle, Inc. is more attractive than National Research Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    HCTI
    Healthcare Triangle, Inc.
    0 0 0
    NRC
    National Research Corp.
    0 0 0
  • Is HCTI or NRC More Risky?

    Healthcare Triangle, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National Research Corp. has a beta of 0.447, suggesting its less volatile than the S&P 500 by 55.256%.

  • Which is a Better Dividend Stock HCTI or NRC?

    Healthcare Triangle, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 2.57% to investors and pays a quarterly dividend of $0.12 per share. Healthcare Triangle, Inc. pays -- of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios HCTI or NRC?

    Healthcare Triangle, Inc. quarterly revenues are $3.5M, which are smaller than National Research Corp. quarterly revenues of $34.6M. Healthcare Triangle, Inc.'s net income of -$1.9M is lower than National Research Corp.'s net income of $4M. Notably, Healthcare Triangle, Inc.'s price-to-earnings ratio is -- while National Research Corp.'s PE ratio is 26.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Triangle, Inc. is 0.26x versus 3.06x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HCTI
    Healthcare Triangle, Inc.
    0.26x -- $3.5M -$1.9M
    NRC
    National Research Corp.
    3.06x 26.53x $34.6M $4M
  • Which has Higher Returns HCTI or SPOK?

    Spok Holdings, Inc. has a net margin of -54.63% compared to Healthcare Triangle, Inc.'s net margin of 9.46%. Healthcare Triangle, Inc.'s return on equity of -153.6% beat Spok Holdings, Inc.'s return on equity of 10.88%.

    Company Gross Margin Earnings Per Share Invested Capital
    HCTI
    Healthcare Triangle, Inc.
    15.91% -$0.43 $10.3M
    SPOK
    Spok Holdings, Inc.
    58.95% $0.15 $156.1M
  • What do Analysts Say About HCTI or SPOK?

    Healthcare Triangle, Inc. has a consensus price target of $6.00, signalling upside risk potential of 159.07%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 62.41%. Given that Healthcare Triangle, Inc. has higher upside potential than Spok Holdings, Inc., analysts believe Healthcare Triangle, Inc. is more attractive than Spok Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    HCTI
    Healthcare Triangle, Inc.
    0 0 0
    SPOK
    Spok Holdings, Inc.
    1 0 0
  • Is HCTI or SPOK More Risky?

    Healthcare Triangle, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.438, suggesting its less volatile than the S&P 500 by 56.19%.

  • Which is a Better Dividend Stock HCTI or SPOK?

    Healthcare Triangle, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.67% to investors and pays a quarterly dividend of $0.31 per share. Healthcare Triangle, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

  • Which has Better Financial Ratios HCTI or SPOK?

    Healthcare Triangle, Inc. quarterly revenues are $3.5M, which are smaller than Spok Holdings, Inc. quarterly revenues of $33.9M. Healthcare Triangle, Inc.'s net income of -$1.9M is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, Healthcare Triangle, Inc.'s price-to-earnings ratio is -- while Spok Holdings, Inc.'s PE ratio is 16.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Triangle, Inc. is 0.26x versus 1.92x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HCTI
    Healthcare Triangle, Inc.
    0.26x -- $3.5M -$1.9M
    SPOK
    Spok Holdings, Inc.
    1.92x 16.16x $33.9M $3.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 22

Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.

Buy
54
BMRN alert for Dec 22

BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.

Buy
82
RKLB alert for Dec 22

Rocket Lab Corp. [RKLB] is up 9.97% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock